🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Joe Wolk, Executive Vice President and Chief Financial Officer, #JNJ, on our Q2 2024 #earnings results. Check out our Investor Relations site for more information: social.jnj.com/4cRHiDq $JNJ

See a recap of our Q2 2024 #earnings here: social.jnj.com/3zOkR3Z $JNJ

We’ve entered into an agreement to acquire V-Wave, a company developing innovative treatment options for patients with heart failure. Click here for more information: social.jnj.com/46Q6fgV

#NEWS: Today we have officially completed our acquisition of V-Wave, a privately-held company developing innovative treatment options for patients with heart failure. Click here for more information: social.jnj.com/3NkF7xM

Join us tomorrow at 8:30 AM ET for a live call and webcast as we share our Q3 2024 results. Register here: social.jnj.com/485XWhN $JNJ #earnings

New: We’ve announced our Q3 2024 earnings results. See the press release for full financial details, non-GAAP reconciliations and cautionary statements: social.jnj.com/3BJAg6x $JNJ #earnings

Join our Q3 2024 #earnings call and webcast now: social.jnj.com/485XWhN $JNJ

Joaquin Duato, Chairman and Chief Executive Officer, #JNJ, on our Q3 2024 #earnings results and financial performance. Read the release for details, non-GAAP reconciliations and cautionary statements: social.jnj.com/3BJAg6x $JNJ

Joe Wolk, Executive Vice President and Chief Financial Officer, #JNJ, on our Q3 2024 #earnings results. Go to our Investor Relations site for more information: social.jnj.com/4058Nqe $JNJ

See a recap of our Q3 2024 #earnings here: social.jnj.com/3Y9QGN0 $JNJ

We're heading to HLTH from October 20-23 to share how we're harnessing innovative technologies to revolutionize healthcare. Swipe to explore what you can learn from our leaders: social.jnj.com/3UgeZbb

We're at HLTH to share how we're using innovative technologies to advance healthcare—including creating more personalized care strategies for patients. Follow along for updates!

How would the world change if everyone had equal access to healthcare? John Legend joined our EVP, Global Corporate Affairs, Vanessa Broadhurst, at @HLTHEvent for a powerful conversation on the importance of driving culturally competent care to unlock health equity.

"Together, advances in science and technology will lead to more effective and personalized treatments." Our Chairman & CEO Joaquin Duato took the stage at HLTH to share why now is the time for bold ambition in healthcare. #HLTHUSA

We're using AI and other innovative technology in new ways to advance healthcare—from improving surgical training and medical procedures to personalizing care for patients around the world. Discover more: social.jnj.com/3Ygnnsr

We’re proud to be recognized as a top 5 company by @atmindex. See how we're harnessing our capabilities, reach and resources to help people around the world get the care they need: social.jnj.com/4hUqajM

Join our Q4 and full-year 2024 #earnings call and webcast now: social.jnj.com/4aejSZa $JNJ

Today we’re breaking ground on our new biologics manufacturing site in Wilson, North Carolina, to help deliver transformational medicines for people living with cancer, immune-mediated, and neurological diseases. Learn more: bit.ly/4htX0H4 #JNJSupplyChain

Join our Q1 2025 #earnings call and webcast now: social.jnj.com/4cuf3vO $JNJ